| Literature DB >> 32260366 |
Andreas Schlattmann1, Knut von Lützau1, Ursula Kaspar1,2, Karsten Becker1,3.
Abstract
Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) remains a serious public health threat. Porcine nasal cavities are predominant habitats of LA-MRSA. Hence, components of their microbiota might be of interest as putative antagonistically acting competitors. Here, an extensive culturomics approach has been applied including 27 healthy pigs from seven different farms; five were treated with antibiotics prior to sampling. Overall, 314 different species with standing in nomenclature and 51 isolates representing novel bacterial taxa were detected. Staphylococcus aureus was isolated from pigs on all seven farms sampled, comprising ten different spa types with t899 (n = 15, 29.4%) and t337 (n = 10, 19.6%) being most frequently isolated. Twenty-six MRSA (mostly t899) were detected on five out of the seven farms. Positive correlations between MRSA colonization and age and colonization with Streptococcus hyovaginalis, and a negative correlation between colonization with MRSA and Citrobacter spp. were found (p < 0.05). Of 209 non-S. aureus members of the Staphylococcaceae family, 25 isolates (12.0%) from three out of the seven farms exhibited methicillin resistance, including two Macrococcus goetzii isolates carrying the mecB gene. Among 125 Enterobacterales, none tested positive for extended-spectrum beta-lactamase (ESBL) and carbapenemase production. The high frequency of methicillin-resistant staphylococci supports the need for enhanced efforts within the "One Health" concept to manage the antibiotic resistance crisis in the human and veterinary medicine sector.Entities:
Keywords: Actinobacteria; ESBL; Enterobacterales; Firmicutes; MRSA; Macrococcus; Proteobacteria; Staphylococcus; microbiota; pig
Year: 2020 PMID: 32260366 PMCID: PMC7232296 DOI: 10.3390/microorganisms8040514
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Data of sampled farms.
| Farm | Total Number of Pigs | Additional Animals on Farm | Feed Consistency | Individual | Age in Months | Antibiotics |
|---|---|---|---|---|---|---|
| #1 | 1400 | Cattle | Solid | #1 | 0.5 | None |
| #2 | 0.5 | None | ||||
| #3 | 0.5 | None | ||||
| #4 | 65 | None | ||||
| #5 | 39 | None | ||||
| #6 | 52 | None | ||||
| #2 | 2000 | Dogs, cats | Liquid and pellets | #1 | 26 | None |
| #2 | 19.5 | None | ||||
| #3 | 26 | None | ||||
| #3 | 3800 | Dogs | Liquid | #1 | 52 | None |
| #2 | 39 | Enrofloxacin | ||||
| #3 | 51.5 | Enrofloxacin | ||||
| #4 | 1000 | Dogs, cats, horses | Liquid | #1 | 3 | None |
| #2 | 3 | None | ||||
| #3 | 3 | None | ||||
| #5 | 2200 | Dogs, horses | Liquid and solid | #1 | 2 | Amoxicillin |
| #2 | 2 | Amoxicillin | ||||
| #3 | 2 | Amoxicillin | ||||
| #6 | 1600 | Dogs | Liquid | #1 | 4 | None |
| #2 | 4 | None | ||||
| #3 | 4 | None | ||||
| #4 | 35.5 | None | ||||
| #5 | 9.5 | None | ||||
| #6 | 29.5 | None | ||||
| #7 | 1600 | Dogs, sheep | Liquid | #1 | 6 | None |
| #2 | 6 | None | ||||
| #3 | 6 | None |
Figure 1Most commonly isolated bacterial species from 54 porcine nasal swab samples.
Figure 2Based Upon Repeat Pattern analysis of 51 isolated spa types. The blue cluster “t337” is the founder of ST337, the yellow cluster “t011” is the founder of ST11; spa types in red text were methicillin-resistant Staphylococcus aureus (MRSA). Sizes of dots represent the number of isolates found in this study, connecting lines indicate evolutionary relatedness among spa types.
Figure 3Most commonly isolated staphylococcal species from 54 porcine nasal swab samples.
Figure 4Non-metric multidimensional scaling plot of all samples. Samples from the same farms are represented by the same symbols.
Figure 5Non-metric multidimensional scaling plot of all samples. Samples from the same habitat are represented by the same symbols. “I” denotes intranasal swab samples, “S” denotes snout surface samples.
Figure 6Non-metric multidimensional scaling plot of all samples. Samples from the same individual are represented by the same symbols. “I” denotes intranasal swab samples, “S” denotes snout surface samples.
Figure 7Non-metric multidimensional scaling plot of all samples. MRSA-positive samples are marked with “+”, MRSA-negative samples are marked with “−” above the symbols. (a) Green triangles represent samples of pigs that were six months of age or younger, blue inverted triangles represent samples of pigs that were older than six months on sampling date. (b) Green triangles represent samples of pigs that were positive for S. hyovaginalis colonization, blue inverted triangles represent samples of pigs that were negative for S. hyovaginalis colonization on sampling date. (c) Green triangles represent samples of pigs that were negative for S. parauberis colonization, blue inverted triangles represent samples of pigs that were positive for S. parauberis colonization on sampling date. (d) Green triangles represent samples of pigs that were positive for Citrobacter sp. colonization, blue inverted triangles represent samples of pigs that were negative for Citrobacter sp. colonization on sampling date.
S. aureus isolates with spa types, detected mecA genes, and phenotypic antimicrobial susceptibility test results.
| Farm | Individual | Sampling Site | Resistance Gene | Phenotypic Antimicrobial Susceptibility Test Profile a | # of Isolates | ||
|---|---|---|---|---|---|---|---|
| CXI Screening | Other Resistances | ||||||
| #1 | #1 | Nasal cavity | t011 | + | + | OXA, BEN, TET | 2 |
| Snout surface | t011 | + | + | OXA, BEN, TET | 1 | ||
| #2 | Nasal cavity | t1298 | n/a | − | BEN, TET | 2 | |
| t337 | n/a | − | BEN, TET | 1 | |||
| Snout surface | t011 | + | + | OXA, BEN, TET | 1 | ||
| t337 | n/a | − | BEN, TET | 2 | |||
| #3 | Nasal cavity | t337 | n/a | − | BEN, TET | 1 | |
| Snout surface | t8893 | n/a | − | BEN, TET | 1 | ||
| t337 | n/a | − | BEN, TET | 4 | |||
| t1419 | n/a | − | BEN, TET, TRS | 2 | |||
| #2 | #2 | Nasal cavity | t337 | n/a | − | BEN | 2 |
| t8893 | n/a | − | BEN | 2 | |||
| Snout surface | t8893 | n/a | − | BEN | 2 | ||
| #3 | #1 | Snout surface | t17059 | n/a | − | LEV, BEN | 1 |
| #2 | Snout surface | t17059 | n/a | − | LEV, BEN | 2 | |
| #4 | #1 | Snout surface | t8893 | n/a | − | BEN | 1 |
| #2 | Snout surface | t034 | + | + | CLI, ERY, BEN, TRS, TET | 1 | |
| #5 | #1 | Nasal cavity | t034 | + | + | CLI, ERY, OXA, BEN, TRS, TET | 2 |
| t034 | + | + | CLI, ERY, OXA, BEN, TET | 1 | |||
| Snout surface | t034 | + | + | CLI, ERY, OXA, BEN, TRS, TET | 1 | ||
| #6 | #2 | Nasal cavity | t899 | + | + | CLI, LEV, OXA, BEN | 1 |
| #3 | Nasal cavity | t899 | n/a | − | LEV, BEN | 1 | |
| t899 | + | + | LEV, OXA, BEN | 3 | |||
| t899 | + | + | CLI, LEV, OXA, BEN | 1 | |||
| Snout surface | t899 | + | + | LEV, OXA, BEN | 9 | ||
| #4 | Snout surface | t2315 | n/a | − | BEN | 1 | |
| #7 | #1 | Nasal cavity | t12359 | + | + | CLI, ERY, OXA, BEN, TRS, TET | 1 |
| Snout surface | t12359 | + | + | CLI, ERY, OXA, BEN, TET | 2 | ||
+, positive; −, negative; n/a, not applicable. a as determined by Vitek 2 using cards AST-P632; BEN, benzylpenicillin; CLI, clindamycin; CXI, cefoxitin; ERY, erythromycin; LEV, levofloxacin; OXA, oxacillin; TET, tetracycline; TRS, trimethoprim/sulfamethoxazole.
Oxacillin-resistant non-S. aureus staphylococci including two Macrococcus goetzii isolates with detected mecA genes and phenotypic antimicrobial susceptibility test results.
| Farm | Individual | Sampling Site | Species | Resistance Gene | Resistances a |
|---|---|---|---|---|---|
| #4 | #1 | Nasal cavity |
|
| FOS, OXA, BEN, TET |
|
|
| CLI, FOS, GEN, CXI, BEN, TET | |||
|
|
| FOS, OXA, BEN, TET | |||
| Snout surface |
|
| FOS, OXA, BEN, TET | ||
|
|
| CLI, FOS, OXA, CXI, BEN | |||
|
|
| CLI, FOS, OXA, CXI, BEN | |||
| #2 | Nasal cavity |
|
| FOS, OXA, CXI, BEN, TET | |
|
|
| FOS, OXA, BEN, TET | |||
|
|
| CLI, OXA, CXI, TET | |||
| Snout surface |
|
| CLI, FOS, GEN, CXI, BEN, TET | ||
|
|
| CLI, ERY, FUS, OXA, CXI, BEN, TRS, TET | |||
| #3 | Nasal cavity |
|
| FOS, OXA, CXI, BEN, TET | |
| #5 | #1 | Nasal cavity |
|
| CLI, DAP, FUS, OXA, CXI |
|
|
| CLI, DAP, FUS, OXA, BEN, TET | |||
|
|
| CLI, ERY, FOS, OXA, TET | |||
| Snout surface |
|
| CLI, ERY, FOS, OXA, CXI, TET | ||
|
|
| CLI, ERY, FOS, OXA, CXI, BEN, TET | |||
|
|
| CLI, ERY, FOS, OXA, CXI, BEN, TET | |||
| #2 | Snout surface |
|
| CLI, ERY, FOS, OXA, CXI, BEN, TET | |
|
|
| CLI, DAP, ERY, FUS, OXA, CXI, BEN, TET | |||
|
|
| CLI, DAP, ERY, FUS, OXA, CXI, BEN, TET | |||
|
|
| CLI, DAP, ERY, FUS, OXA, CXI, BEN, TET | |||
|
|
| CLI, ERY, FOS, GEN, OXA, CXI, BEN, TET | |||
| #7 | #2 | Snout surface |
|
| CLI, ERY, FOS, OXA, CXI, BEN, TET |
| #3 | Snout surface |
|
| CLI, ERY, FOS, OXA, BEN, TET |
a as determined by Vitek 2 using cards AST-P632; BEN, benzylpenicillin; CLI, clindamycin; CXI, cefoxitin; ERY, erythromycin; FOS, fosfomycin; FUS, fusidic acid; LEV, levofloxacin; OXA, oxacillin; TET, tetracycline; TRS, trimethoprim/sulfamethoxazole.